Orforglipron
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 974
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Orforglipron (GZL1) | n/r | n/r | n/r | n/r | n/r |
| Orforglipron (GZL2) | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.